ÂÜÀòÂÒÂ×

Brian McVeigh is the Chairman, Chief Executive Officer, and Co-Founder of Code BioTherapeutics, where leadership focuses on innovative genetic medicine delivery for serious genetic diseases. McVeigh also serves as Executive Chairman and Co-Founder of 4BIO Capital, a venture capital firm specializing in advanced therapies, and holds positions in various biotechnology companies, including Chairman of the Board for Genisphere and Executive Chairman at Araris Biotech AG. Additionally, McVeigh provides strategic advisory services at UPMC Enterprises and Longview Innovation while maintaining roles at SciNeuro Pharmaceuticals and SG3 Ventures LLC. McVeigh's previous experience includes leading Redpin Therapeutics through crucial stages of development and serving as Chief Business Officer at Zafgen, Inc. Academic credentials include a B.S. in Accounting and Finance from La Salle University, an M.B.A. from Villanova University, and a post-master's certificate in Pharmaceutical Marketing from Saint Joseph's University.